Absence of proteolysis of insulin-like growth factor binding protein-3 in serum from patients with growth hormone deficiency

Makoto Yamada, Tomonobu Hasegawa, Yukihiro Hasegawa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Insulin-like growth factor-I (IGF-I) is predominantly bound to IGF binding protein-3 (IGFBP-3), and free form of IGF-I (fIGF-I) may be bioactive in the circulation. Proteolysis of IGFBP-3, as reported in pregnant serum, results in the lowering of the affinity for IGF-I, thereby increasing the ratio of fIGF-I to total IGF-I (f/t IGF-I ratio). Conflicting results have been reported regarding the relationship between the proteolysis and growth hormone (GH)-IGF-I axis. Proteolysis of IGFBP-3 was previously reported to be present late at night in serum from pediatric subjects with GH receptor dysfunction (GHRD or 'Laron-type dwarfism'). Recently, it was reported that proteolysis of IGFBP-3 could not be detected in adult patients with GH deficiency (GHD). The purpose of this study was to investigate the possible relationship between proteolysis of IGFBP-3 and GH in patients with GHD including pediatric cases. Here, proteolysis of IGFBP-3 measured by Western immunoblotting (ages 4-25 years; n = 11) and f/t IGF-I ratio measured by immunoradiometric assay (ages 4-25 years; n= 10) were studied in patients with GHD, which is similar to GHRD in terms of lowered GH function. There was no significant proteolysis of IGFBP-3 in the sera from the 11 patients with GHD. No proteolysis of IGFBP-3 was observed during a 24 hour period in sera obtained every two hours from two patients with GHD. f/t IGF-I ratio was not increased in plasma from the 10 patients with GHD. Our data suggest that proteolysis of IGFBP-3 is independent of the GH-IGF-I axis.

Original languageEnglish
Pages (from-to)717-722
Number of pages6
JournalEndocrine Journal
Volume46
Issue number5
Publication statusPublished - 1999 Oct

Fingerprint

Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor I
Proteolysis
Growth Hormone
Serum
Laron Syndrome
Pediatrics
Somatotropin Receptors
Immunoradiometric Assay
Western Blotting

Keywords

  • Free/total IGF-I ratio
  • Growth hormone deficiency (GHD)
  • IGF binding protein-3 (IGFBP- 3)
  • Insulin-like growth factor-I (IGF-I)
  • Proteolysis of IGFBP-3
  • Western immunoblotting

ASJC Scopus subject areas

  • Endocrinology

Cite this

Absence of proteolysis of insulin-like growth factor binding protein-3 in serum from patients with growth hormone deficiency. / Yamada, Makoto; Hasegawa, Tomonobu; Hasegawa, Yukihiro.

In: Endocrine Journal, Vol. 46, No. 5, 10.1999, p. 717-722.

Research output: Contribution to journalArticle

@article{4e3d57c28dbb4c24b9e9bac1573b9568,
title = "Absence of proteolysis of insulin-like growth factor binding protein-3 in serum from patients with growth hormone deficiency",
abstract = "Insulin-like growth factor-I (IGF-I) is predominantly bound to IGF binding protein-3 (IGFBP-3), and free form of IGF-I (fIGF-I) may be bioactive in the circulation. Proteolysis of IGFBP-3, as reported in pregnant serum, results in the lowering of the affinity for IGF-I, thereby increasing the ratio of fIGF-I to total IGF-I (f/t IGF-I ratio). Conflicting results have been reported regarding the relationship between the proteolysis and growth hormone (GH)-IGF-I axis. Proteolysis of IGFBP-3 was previously reported to be present late at night in serum from pediatric subjects with GH receptor dysfunction (GHRD or 'Laron-type dwarfism'). Recently, it was reported that proteolysis of IGFBP-3 could not be detected in adult patients with GH deficiency (GHD). The purpose of this study was to investigate the possible relationship between proteolysis of IGFBP-3 and GH in patients with GHD including pediatric cases. Here, proteolysis of IGFBP-3 measured by Western immunoblotting (ages 4-25 years; n = 11) and f/t IGF-I ratio measured by immunoradiometric assay (ages 4-25 years; n= 10) were studied in patients with GHD, which is similar to GHRD in terms of lowered GH function. There was no significant proteolysis of IGFBP-3 in the sera from the 11 patients with GHD. No proteolysis of IGFBP-3 was observed during a 24 hour period in sera obtained every two hours from two patients with GHD. f/t IGF-I ratio was not increased in plasma from the 10 patients with GHD. Our data suggest that proteolysis of IGFBP-3 is independent of the GH-IGF-I axis.",
keywords = "Free/total IGF-I ratio, Growth hormone deficiency (GHD), IGF binding protein-3 (IGFBP- 3), Insulin-like growth factor-I (IGF-I), Proteolysis of IGFBP-3, Western immunoblotting",
author = "Makoto Yamada and Tomonobu Hasegawa and Yukihiro Hasegawa",
year = "1999",
month = "10",
language = "English",
volume = "46",
pages = "717--722",
journal = "Endocrine Journal",
issn = "0918-8959",
publisher = "Japan Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Absence of proteolysis of insulin-like growth factor binding protein-3 in serum from patients with growth hormone deficiency

AU - Yamada, Makoto

AU - Hasegawa, Tomonobu

AU - Hasegawa, Yukihiro

PY - 1999/10

Y1 - 1999/10

N2 - Insulin-like growth factor-I (IGF-I) is predominantly bound to IGF binding protein-3 (IGFBP-3), and free form of IGF-I (fIGF-I) may be bioactive in the circulation. Proteolysis of IGFBP-3, as reported in pregnant serum, results in the lowering of the affinity for IGF-I, thereby increasing the ratio of fIGF-I to total IGF-I (f/t IGF-I ratio). Conflicting results have been reported regarding the relationship between the proteolysis and growth hormone (GH)-IGF-I axis. Proteolysis of IGFBP-3 was previously reported to be present late at night in serum from pediatric subjects with GH receptor dysfunction (GHRD or 'Laron-type dwarfism'). Recently, it was reported that proteolysis of IGFBP-3 could not be detected in adult patients with GH deficiency (GHD). The purpose of this study was to investigate the possible relationship between proteolysis of IGFBP-3 and GH in patients with GHD including pediatric cases. Here, proteolysis of IGFBP-3 measured by Western immunoblotting (ages 4-25 years; n = 11) and f/t IGF-I ratio measured by immunoradiometric assay (ages 4-25 years; n= 10) were studied in patients with GHD, which is similar to GHRD in terms of lowered GH function. There was no significant proteolysis of IGFBP-3 in the sera from the 11 patients with GHD. No proteolysis of IGFBP-3 was observed during a 24 hour period in sera obtained every two hours from two patients with GHD. f/t IGF-I ratio was not increased in plasma from the 10 patients with GHD. Our data suggest that proteolysis of IGFBP-3 is independent of the GH-IGF-I axis.

AB - Insulin-like growth factor-I (IGF-I) is predominantly bound to IGF binding protein-3 (IGFBP-3), and free form of IGF-I (fIGF-I) may be bioactive in the circulation. Proteolysis of IGFBP-3, as reported in pregnant serum, results in the lowering of the affinity for IGF-I, thereby increasing the ratio of fIGF-I to total IGF-I (f/t IGF-I ratio). Conflicting results have been reported regarding the relationship between the proteolysis and growth hormone (GH)-IGF-I axis. Proteolysis of IGFBP-3 was previously reported to be present late at night in serum from pediatric subjects with GH receptor dysfunction (GHRD or 'Laron-type dwarfism'). Recently, it was reported that proteolysis of IGFBP-3 could not be detected in adult patients with GH deficiency (GHD). The purpose of this study was to investigate the possible relationship between proteolysis of IGFBP-3 and GH in patients with GHD including pediatric cases. Here, proteolysis of IGFBP-3 measured by Western immunoblotting (ages 4-25 years; n = 11) and f/t IGF-I ratio measured by immunoradiometric assay (ages 4-25 years; n= 10) were studied in patients with GHD, which is similar to GHRD in terms of lowered GH function. There was no significant proteolysis of IGFBP-3 in the sera from the 11 patients with GHD. No proteolysis of IGFBP-3 was observed during a 24 hour period in sera obtained every two hours from two patients with GHD. f/t IGF-I ratio was not increased in plasma from the 10 patients with GHD. Our data suggest that proteolysis of IGFBP-3 is independent of the GH-IGF-I axis.

KW - Free/total IGF-I ratio

KW - Growth hormone deficiency (GHD)

KW - IGF binding protein-3 (IGFBP- 3)

KW - Insulin-like growth factor-I (IGF-I)

KW - Proteolysis of IGFBP-3

KW - Western immunoblotting

UR - http://www.scopus.com/inward/record.url?scp=0032728747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032728747&partnerID=8YFLogxK

M3 - Article

VL - 46

SP - 717

EP - 722

JO - Endocrine Journal

JF - Endocrine Journal

SN - 0918-8959

IS - 5

ER -